0 NYSE Companies - September 3, 2019FTI Consulting Report Finds African Leaders Have Opportunity to Embrace a High-Growth, Low-Emission FutureRead More
0 NASDAQ Companies - September 3, 2019Chi-Med to Participate in the Morgan Stanley 17th Annual Global Healthcare ConferenceRead More
0 NYSE Companies - September 3, 2019Teledyne présente ses capacités de défense avancées au salon DSEI 2019Read More
0 NYSE Companies - September 3, 2019Teledyne e2v gibt neue CMOS-Sensoren Familie speziell für Anwendungen mit 3D-Lasertriangulation bekanntRead More
0 NYSE Companies - September 3, 2019Teledyne e2v annonce la sortie de sa nouvelle famille de capteurs CMOS, conçue pour les applications 3D de triangulation laserRead More
0 NYSE Companies - September 3, 2019Teledyne bringt seine erweiterten Verteidigungsfähigkeiten zur DSEI 2019Read More
0 NASDAQ Companies - September 3, 2019Chi-Med Initiates an International Phase I/Ib Trial of HMPL-689 in Patients with Advanced Relapsed or Refractory LymphomaRead More
0 NASDAQ Companies - September 3, 2019Verona Pharma to Present at H.C. Wainwright 21st Annual Global Investment ConferenceRead More
0 NASDAQ Companies - September 3, 2019Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/DiabetesRead More
0 NASDAQ Companies - September 3, 2019Autolus Announces Publication in Nature Medicine of Data Supporting the Development of AUTO1 for Treatment of Patients with ALLRead More
